Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
Key Highlights
- ➤Progyny will present Menopause and Midlife program research October 22.
- ➤Study evaluates access, engagement, and symptom changes among participating women.
- ➤Research partnership includes Morehouse School of Medicine.
- ➤Progyny will exhibit at The Menopause Society 2026 Annual Meeting October 20–24.
Expert Statements
Janet Choi, MD, Chief Medical Officer, Progyny
“Menopause is a significant health transition, yet too many women still struggle to find clinicians with the expertise to provide individualized, evidence-based care.”
Janet Choi, MD, Chief Medical Officer, Progyny
“This research demonstrates the potential to translate menopause expertise into a model that can reach more women and meaningfully improve their symptoms.”
Janet Choi, MD, Chief Medical Officer, Progyny
“That’s an important step toward making high-quality menopause care a more accessible part of women’s healthcare.”
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating real-world outcomes from its Menopause and Midlife program and exhibit at The Menopause Society 2026 Annual Meeting in San Diego, October 20 – 24, 2026.
As a leading provider of employer-sponsored menopause care around the globe, Progyny is committed to expanding access to high quality, evidence-based care and demonstrating its impact on women's health outcomes. The research, “Scaling Access to Menopause Care: Real-World Symptom Improvement in an Employer-Sponsored Program,” will be presented by Gloria Richard-Davis, MD, MBA, Regional Dean at Morehouse School of Medicine, member of Progyny’s Medical Advisory Board, and former Secretary and two-term member of The Menopause Society’s Board of Trustees. The study was conducted in partnership with Morehouse School of Medicine and evaluated access, engagement, and changes in menopause symptoms among women participating in Progyny’s employer-sponsored Menopause and Midlife program.
Get started
Create a free account to read the full story.